The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all.
Vertex Pharmaceuticals reported on Monday that it beat Wall Street estimates for third-quarter results, driven by strong demand for its cystic fibrosis treatments and early contributions from newer ...
Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively ...
Abstract: Graph Neural Networks (GNNs) have revolutionized many Machine Learning (ML) applications, such as social network analysis, bioinformatics, etc. GNN inference can be accelerated by exploiting ...